Verastem Oncology Announces Fourth Quarter and Full-Year 2018 Financial Results and Corporate Developments

Go back to Verastem Oncology Announces Fourth Quarter and Full-Year 2018 Financial Results and Corporate Developments
VERASTEM SHS (NASDAQ: VSTM) Delayed: 10.06 --0 (-0%)
Previous Close $10.06    52 Week High $2.43 
Open $10.06    52 Week Low $1.05 
Day High $10.06    P/E N/A 
Day Low $10.06    EPS $-1.79 
Volume 1,385